The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Paclitaxel-eluting stents versus everolimus-eluting coronary stents in a diabetic population: two-year follow-up of the TUXEDO-India trial

EuroIntervention 2017;13:1194-1201 published online July 2017. DOI: 10.4244/EIJ-D-17-00333

1. Department of Cardiology, Fortis Escorts Heart Institute, New Delhi, India; 2. Department of Interventional Cardiology, Kamalnayan Bajaj Hospital, Aurangabad, India; 3. Department of Cardiology, Holy Family Hospital - Diagnostic Services, Mumbai, India

Aims: The aim of this study was to report whether the superiority of the everolimus-eluting stent (EES) vs. the paclitaxel-eluting stent (PES) at one-year follow-up in the Taxus Element v

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Clinical outcomes after percutaneous coronary intervention with the COMBO stent versus Resolute Integrity and PROMUS Element stents: a propensity-matched analysis